Hot Pursuit     19-Sep-22
Alembic Pharmaceuticals Ltd down for fifth straight session
Alembic Pharmaceuticals Ltd is quoting at Rs 608.2, down 0.28% on the day as on 13:19 IST on the NSE. The stock tumbled 34.24% in last one year as compared to a 1.29% rally in NIFTY and a 12.82% fall in the Nifty Metal index.

Alembic Pharmaceuticals Ltd dropped for a fifth straight session today. The stock is quoting at Rs 608.2, down 0.28% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.51% on the day, quoting at 17620.7. The Sensex is at 59118.57, up 0.47%.Alembic Pharmaceuticals Ltd has lost around 6.39% in last one month.Meanwhile, Nifty Metal index of which Alembic Pharmaceuticals Ltd is a constituent, has eased around 2.37% in last one month and is currently quoting at 12346.85, down 0.46% on the day. The volume in the stock stood at 55341 shares today, compared to the daily average of 1.11 lakh shares in last one month.

The PE of the stock is 17.82 based on TTM earnings ending June 22.

Previous News
  Stock Alert: Alembic Pharma, Bajel Projects, Zydus Lifesciences, Lupin, Adani Enterprises, Biocon
 ( Market Commentary - Stock Alert 30-Sep-24   08:34 )
  Alembic Pharma gets USFDA nod for Doxycycline Capsules
 ( Hot Pursuit - 28-Jun-24   12:20 )
  Alembic Pharma's oncology formulation facility undergoes USFDA audit
 ( Corporate News - 09-Mar-24   12:26 )
  Volumes soar at Jubilant Pharmova Ltd counter
 ( Hot Pursuit - 09-Sep-24   14:30 )
  Alembic Pharma Q3 PAT slips 29% YoY; R&D spend at Rs 157 crore
 ( Hot Pursuit - 02-Feb-23   10:41 )
  Alembic Pharma’s Gujarat unit gets EIR from USFDA
 ( Hot Pursuit - 28-Sep-24   13:02 )
  Alembic Pharma’s Gujarat facility gets 4 observations from USFDA
 ( Hot Pursuit - 09-Mar-24   09:04 )
  Alembic Pharmaceuticals Ltd leads losers in 'A' group
 ( Hot Pursuit - 09-Aug-24   15:00 )
  Board of Alembic Pharmaceuticals recommends Interim dividend
 ( Corporate News - 05-Aug-22   10:48 )
  Alembic Pharmaceuticals gets US FDA nod for antibiotic drug
 ( Hot Pursuit - 04-Jan-22   11:31 )
  Alembic Pharma receives PAS approval for its sANDA Pregabalin Capsules
 ( Corporate News - 22-Dec-22   13:53 )
Other Stories
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
  GRSE bags Rs 226-cr LoA from West Bengal Govt
  04-Oct-24   14:40
  Volumes soar at Avenue Supermarts Ltd counter
  04-Oct-24   14:30
  Real Estate stocks edge lower
  04-Oct-24   14:00
  Auto stocks edge lower
  04-Oct-24   14:00
  Utilties stocks edge lower
  04-Oct-24   14:00
  HDFC Bank Ltd down for fifth straight session
  04-Oct-24   13:35
Back Top